Akshay Agarwal, M.Pharm,Founder, Kivonyx Healthcare
India’s pharmaceutical industry is one of the largest in the world and continues to grow rapidly. The Indian Brand Equity Foundation projects that by 2030, the Indian pharmaceutical sector will reach USD 130 billion, mainly due to its large domestic market and robust export growth. Hence, several aspiring entrepreneurs and healthcare professionals are looking for ways to make an entry into the pharma business.
The most successful ways to operate in the pharma sector are by setting up two types of businesses: PCD Pharma Franchise and Third Party Manufacturing (Contract Manufacturing). Both these models allow individuals and companies to be a part of the pharmaceutical business without the cost of setting up their own manufacturing plant, but the cost, responsibility, profit margins and nature of business for both these models are entirely different.
What is a PCD Pharma Franchise?
A PCD Pharma Franchise stands for the word Propaganda Cum Distribution Pharma Franchise. This is a business where a pharmaceutical company appoints a Franchise Partner for marketing and distribution of its pharmaceutical products in a defined territory. The PCD Franchise Partner has to purchase the products from the Parent company and then sell the same in their territory under the brand name of the Parent company.
PCD Pharma Franchise is one of the most sought-after business models all across India due to its very low investment & a pre- established product portfolio.
Key Aspects of a PCD Pharma Franchise:
- A guaranteed Monopoly for the assigned territory
- A pre-established product portfolio
- Marketing support by the pharmaceutical company
- Low investment (no production facilities)
The business partners are basically concentrated on sales, marketing and distribution of the pharmaceutical products, and it is the company that takes the responsibility for production, quality control, and government approval of pharmaceutical products.
What is Third-Party Manufacturing?
Third-party manufacturing, also called contract manufacturing, is a model where a business owner hires an external manufacturer to produce drugs that are then sold under the owner’s own brand.
Since India has a strong manufacturing infrastructure and regulations, it is a key contract manufacturer; the Department of Pharmaceuticals of the Government of India claims there are over 3,000 pharmaceutical companies in India with about 10,500 units, making production outsourcing easier and convenient.
Key Aspects of Third-Party Manufacturing:
- Total ownership of product branding
- Possibility to establish your own pharmaceutical brand
- Increased control of the market prices and sales efforts
- Product registration and regulatory compliance needed
- Increased investment as compared to the PCD franchise.
Third-party manufacturing is usually selected by businesses that want to develop their own pharmaceutical brand on the market.
Major Differences Between PCD Pharma Franchise and Third-Party Manufacturing
| Factor | PCD Pharma Franchise | Third-Party Manufacturing |
| Business Type | Distribution model | Brand ownership model |
| Investment | Low | Moderate to high |
| Brand Ownership | Company brand | Your own brand |
| Manufacturing Responsibility | Handled by the parent company | Handled by a contract manufacturer |
| Marketing Responsibility | Franchise partner | Brand owner |
| Risk Level | Lower | Higher |
| Profit Potential | Moderate | Higher in the long term |
Investment Comparison
Investment for PCD Pharma Franchise
Investment in setting up a PCD Pharma franchise is normally in the range of ₹50,000-₹2,00,000 based on the product portfolio and company practices.
Major costs would be:
- Initial purchasing of products
- Drug License and GST registration
- Marketing collaterals
- Distribution expenses
Since the company would provide the brand, promotional support and portfolio of products, the investment would be comparatively low.
Third-Party Manufacturing Investment
Third-party manufacturing requires a higher investment since you are building your own brand. Higher investment since you are building your own brand.
You generally have to invest somewhere between ₹3 lakh and ₹15 lakh, based on:
- The product development
- Packaging design
- MOQs (Minimum Order Quantities)
- Marketing activities
- Regulatory requirements and submissions.
You also need to do branding and distribution by yourself.
Profit Potential Comparison
PCD Pharma Franchise
Generally, the profit margins are about 15%-40%, depending on the product and marketing strategy.
As the brand is already known to the customers, the entry into the market becomes faster, and revenue generation is also smooth and continuous.
Third-party Manufacturing
Long-term higher profit generation can be obtained here, as the ownership of the brand lies with you.
Profit margin is up to 50% and more as the brand grows and the demand goes up.
But the initial risk and marketing pressure are quite high.
Which Model is Better for Beginners?
If someone is new to the business of pharma, a PCD Pharma Franchise is often the preferred choice of commencement. This is primarily due to:
- Lower investment cost
- Easy operational control
- Established support of the brand
- Speedy market entry
Doctors, medical representatives, and healthcare entrepreneurs commonly choose this approach to embark on the journey of pharma.
When Should You Choose Third-Party Manufacturing?
You can opt for contract manufacturing if you:
- Wish to develop your own brand of drugs.
- Have an established distribution channel/marketing network;
- Intend to expand to national or international levels.
- And have the funds to spend on brand building and marketing efforts.
This model is ideal for long-term brand building and a better profit margin.
Market Growth Supporting Both Models
India maintains its status as a leading pharmaceutical nation.
The India Brand Equity Foundation states that India provides more than 50% of worldwide vaccine needs and supplies 40% of the generic medications used in the United States, and India accounts for 20% of the global distribution of generic drugs.
The franchise distribution business and the contract manufacturing business both receive significant benefits from the rapid growth that this industry development brings.
Conclusion
Both PCD Pharma Franchise and Third Party Manufacturing are profitable venture options for the rapidly growing pharmaceutical industry of India.
The PCD Pharma Franchise is the most suitable option if one seeks to begin with low investment and minimal risks, as in this case, you are provided with readymade products, marketing support and a brand that is already recognised by the market.
However, if one wishes to set up their very own pharmaceutical brand, with substantial profits at the long end, then third-party manufacturing might just be a preferable option, albeit it demands a considerable investment along with responsibilities.
In the end, it all boils down to business goals, investment capability and risk aversion with respect to branding and marketing. Once a close eye is put on these aspects, one can rightly identify the preferred option to start an enterprise in the pharmaceutical industry.
Author Bio:
With a background in Pharmacy (M.Pharm) and over 20 years in the industry, Akshay Agarwal leads Kivonyx Healthcare with a mission to empower pharmaceutical entrepreneurs across India. He specializes in creating ethical PCD franchise models that combine high-quality formulations with robust distributor support.
